Next Article in Journal
Efficacy of Age-Specific High-Intensity Stretch-Shortening Contractions in Reversing Dynapenia, Sarcopenia, and Loss of Skeletal Muscle Quality
Previous Article in Journal
The Epidemic of Obesity and Poor Physical Activity Participation: Will We Ever See a Change?
Open AccessConcept Paper

Multiparametric Approach to Arrhythmogenic Cardiomyopathy: Clinical, Instrumental, and Lifestyle Indications

Clinical and Experimental Medicine Department, School of Sports Medicine, Sports Medicine and Exercise Center, 50141 Florence, Italy
*
Author to whom correspondence should be addressed.
J. Funct. Morphol. Kinesiol. 2018, 3(2), 35; https://doi.org/10.3390/jfmk3020035
Received: 11 April 2018 / Revised: 16 May 2018 / Accepted: 8 June 2018 / Published: 13 June 2018
(This article belongs to the Special Issue Arrhythmic Events in Sports Medicine and Kinesiology)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder with an autosomal dominant inheritance and incomplete penetrance. It predominantly affects the right ventricle (RV), predisposing to the origin of ventricular arrhythmias and sudden death (SD). The structural basis of the disease consists of the progressive loss of myocardium with fibro-adipose replacement. ARVC is a “desmosomes” disease involving mutations of proteins such as placoglobin, desmoplachine, placophylline, desmoglein, and desmocollin. In the “classical” form, the disease mainly implicates the RV chamber, while the left ventricle (LV) is involved in advanced stages. Genotype-phenotype correlation studies have identified some phenotypic variants characterized by an early participation of the LV, which can proceed in parallel toward the two ventricles (“biventricular” variant) or prevails over the RV (variant to “left dominance”). These data led to the evolution of the initial definition of ARVC, which is currently considered a genetic disease of both ventricles and, therefore, deserves the denomination “arrhythmogenic cardiomyopathy”. Many aspects of diagnosis, treatment, and indications for a correct lifestyle are important in sports medicine. This paper will discuss the clinical management of ARVC, with particular reference to diagnosis, risk stratification, therapy, and indications for physical activity. View Full-Text
Keywords: sudden death; arrhythmogenic right ventricular cardiomyopathy; athletes sudden death; arrhythmogenic right ventricular cardiomyopathy; athletes
Show Figures

Figure 1

MDPI and ACS Style

Stefani, L.; Tosi, B.; Galanti, G. Multiparametric Approach to Arrhythmogenic Cardiomyopathy: Clinical, Instrumental, and Lifestyle Indications. J. Funct. Morphol. Kinesiol. 2018, 3, 35.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Back to TopTop